Back to Search
PAUL IANNINI, M.D.
M.D.
Infectious Disease Physician
NPI: 1114013596Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD431902(PA)
Research & Publications (20)
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
PMID 17559736·Curr Med Res Opin·2007
6-review
Adverse cutaneous reactions and drugs: a focus on antimicrobials.
PMID 16736880·J Chemother·2006
6-review
Cutaneous adverse events and gemifloxacin: observations from the clinical trial program.
PMID 16572887·J Chemother·2006
6-review
Prevention and management of antibacterial resistance for primary care patients with respiratory tract infections.
PMID 14570346·South Med J·2003
6-review
Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.
PMID 12904146·Expert Opin Drug Saf·2002
6-review
Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.
PMID 17640109·Pharmacoeconomics·2007
4-observational
A case series of macrolide treatment failures in community acquired pneumonia.
PMID 18073153·J Chemother·2007
4-observational
Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections.
PMID 16614685·MedGenMed·2005
6-review
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
PMID 15546106·Clin Infect Dis·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 870 WESTOVER LN
YORK, PA 17403 - Phone
- (717) 650-6489
Quick Facts
- NPI
- 1114013596
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile